New ointment for Sun-Damaged skin spots enters early human testing
NCT ID NCT07318675
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests an experimental ointment called HW211026 in 40 adults with actinic keratosis, a common skin condition caused by sun damage. The main goal is to check if the ointment is safe and how the body absorbs it. Participants will apply the ointment once or several times to a small area on their face.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACTINIC KERATOSIS (AK) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shanghai Skin Disease Hospital
RECRUITINGShanghai, 200443, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a reformulated gel plus light therapy better tackle precancerous skin spots?
- Can a five-day ointment improve sun-damaged skin? new study investigates
- New cream could zap precancerous skin spots
- Can a special sunscreen stop skin spots from turning dangerous?
- Half the time, same effect? new study tests shorter light therapy for scalp lesions
- Simple cream may shield transplant patients from skin cancer